SUDIP K. DAS
Also known as: Sudip Das
Indiana University School of Medicine, Butler University, Idaho State University
About
Dr. Sudip Das has over thirty years of teaching and research experience in the professional pharmacy and graduate programs in the USA and Canada. Dr. Das is the Director of the Graduate Program and Research in Pharmaceutical Sciences and Professor of Pharmaceutics at the College of Pharmacy & Health Sciences, Butler University, Indianapolis, IN, where he also served as the chair of the Department of Pharmaceutical Sciences from 2004-09. After obtaining an undergraduate degree in pharmacy, an MPharm and a PhD in Pharmaceutics from Jadavpur University, India, Dr. Das pursued postgraduate training as a UNIDO scholar in pharmaceutical technology at the State University of Gent, Belgium. He was awarded the Young Scientist award by the Indian Science Congress (highest honor for Indian scientists below the age of 30 years presented by the Prime Minister of India) in 1989 for his PhD research. He continued postdoctoral training at The University of Queensland, Australia, following which he accepted a faculty position at Memorial University of Newfoundland, Canada. Before joining Butler, Dr. Das held faculty positions in pharmacy colleges at Nova Southeastern University and Idaho State University.
Dr. Das has supervised a number of postdoctoral, graduate and undergraduate research students, and was the key faculty responsible for the reinstatement of the graduate program and research infrastructure in pharmaceutical sciences at Butler University. His current research involves targeted delivery of siRNA and nano-composites for the treatment of cancer and neurodegenerative diseases. Dr. Das has over 150 research publications, review articles, patents, proceedings, conference presentations and book chapters. He is a recipient of multiple awards/honors and has secured extramural research funding from NIH, PDA, and the pharmaceutical industry.
Dr. Das has been an active member of AACP since 1993-94. He became an AACP Leadership Fellow (2005), and served as the chair-elect, chair and immediate past chair of the Teachers of Pharmaceutics Section (2006-09). From 2008-11, Dr. Das served as the founding chair and immediate past chair of the AACP Council of Sections, where he led the task of developing the mission and goals of the new council and created various task forces supporting the missions of the AACP sections. He has also served on the AACP Board of Directors (2008-11), AACP Research & Graduate Affairs and the Bylaws and Policy Development Committees, along with various AACP Task Forces.
Dr. Das is also an active member of the American Association of Pharmaceutical Scientists (AAPS) (since 1991) and Controlled Release Society (since 1987). He has served on many committees of the PDD/PPB and BIOTEC sections of AAPS. Since 2004, he has served on several study sections for the NIH - Center for Scientific Review and continues to serve on the editorial boards of American Journal of Pharmaceutical Education, Therapeutic Delivery and a number of drug delivery journals.
Employment
-
Indiana University School of Medicine Adjunct Professor2019 - Present
-
Butler University Professor2004 - Present
-
Idaho State University Associate Professor1998 - 2004
-
Nova Southeastern University Assistant Professor of Pharmaceutics1993 - 1998
-
Memorial University of Newfoundland Assistant Professor of Pharmaceutics1991 - 1993
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (76)
- Implementing Standards 2025: Recommendations to Prepare Graduates for Advancements in Practice and Enhance Program Quality Save
- Characterization of a custom 3D-printed microfluidic aerosolizer for enhanced nose-to-brain delivery of nanoemulsion. Save
- Abstract 1661: Development of a patient-derived glioblastoma model in the transgenic Rag2 Null rat: In vivo imaging, histology, and combination therapy assessment Save
- Novel Therapeutics and drug-delivery Approaches in the Modulation of Glioblastoma Stem Cell Resistance Save
- Lessons Learned From the COVID-19 Pandemic and the Implications for Pharmaceutical Graduate Education and Research Save
- Development of CD133 Targeting Multi-Drug Polymer Micellar Nanoparticles for Glioblastoma - In Vitro Evaluation in Glioblastoma Stem Cells Save
- Aerosolized In Vivo 3D Localization of Nose-to-Brain Nanocarrier Delivery Using Multimodality Neuroimaging in a Rat Model—Protocol Development Save
- Special focus issue on drug delivery strategies for the treatment of cancer Save
- Surface Modification Strategies in Enhancing Systemic Delivery Performance Save
- Development of targetable multi-drug nanoparticles for glioblastoma treatment and in vitro evaluation in glioblastoma stem cells Save